Modern Diagnostic & Research C Share Price & Stock Analysis

Modern Diagnostic & Research C (BSE: 544673) is a Gurugram, Haryana-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹88 Cr, it ranks #3,348 by market cap among the 6,197 Indian listed companies on FinBizNet, and #12 of 18 in Medical Diagnostic Centres. At ₹58.00 (as of 16 Nov 2026), the share price is 42.0% below its 52-week high of ₹100.00 and 28.9% above its 52-week low of ₹45.00.

Key Metrics

Current Price₹58.00
Market Cap₹88 Cr
BSE Code544673
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Services > Medical Diagnostic Centres
P/E Ratio16.7
Return on Assets5.64%
52-Week Range₹45.00 – ₹100.00
3-Month Price Change+16.0%
Beta (1Y)0.86
HeadquartersGurugram, Haryana
Websitewww.mdrcindia.com

Shareholding and Delivery

Delivery averaged 92.1% of traded volume across 12 BSE sessions (21 Oct 2026 – 11 Nov 2026).

About Modern Diagnostic & Research C

Modern Diagnostic & Research Centre Limited provides diagnostic and related healthcare tests services to individual patients, corporates, hospitals and other healthcare providers in India. It offers diagnostic tests, such as complete blood counts, liver and kidney function tests, lipid profiles, hormone analysis, autoimmune disease markers, cancer screening, and infectious disease testing; and radiology services magnetic resonance imaging, computerized tomography scan (CT) scans, PET-CT, ultrasound, color Doppler studies, digital X-rays, mammography, and interventional radiology, as well as heart lab, neuro lab and laboratory, electrocardiogram, cone beam CT, orthopantomogram, pulmonary function tests, etc. The company also provides pathology services, such as haematology, biochemistry, clinical pathology, serology, immunology, histopathology, cytopathology, microbiology, molecular diagnostics, and genetic testing. In addition, it offers value-added services, including home collection

Products and Services

1. Radiology-This segment offers non-invasive diagnostic techniques to check the functionality of vital body organs, such as heart, lungs, and brain. It includes EEG, CT scan, MRI Scan1, and ultrasound scan. 2. Pathology-This segment engages in testing blood, urine, or other body fluids to check for infections while use of medical imaging techniques to diagnose and treat diseases and injuries. 3. NA-NA 4. NA-NA

Modern Diagnostic & Research C vs Peers — Medical Diagnostic Centres

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Dr. Lal Pathlabs Ltd₹33,934 Cr66.421.48%₹874 Cr+28.7%
Vijaya Diagnostic Centre Limited₹14,665 Cr84.319.70%₹255 Cr+38.5%
Metropolis Healthcare Limited₹11,952 Cr61.513.37%₹497 Cr+14.9%
Throcare Technologies Ltd₹7,764 Cr47.628.74%₹271 Cr+7.5%
SURAKSHA DIAGNOSTIC LIMITED₹1,856 Cr55.413.84%₹99 Cr+6.9%
Krsnaa Diagnostics Ltd₹1,625 Cr16.810.89%₹271 Cr-27.0%
Gaudium IVF and Women Health Limited₹803 Cr27.416.08%₹37 Cr—
Chandan Healthcare Limited₹582 Cr21.918.43%₹81 Cr—
Modern Diagnostic & Research C₹88 Cr16.7———

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Modern Diagnostic & Research C?

Modern Diagnostic & Research C is trading at ₹58.00, with a market capitalisation of ₹88 Cr.

Which sector does Modern Diagnostic & Research C belong to?

Modern Diagnostic & Research C operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).

What are the key financial ratios of Modern Diagnostic & Research C?

Modern Diagnostic & Research C has a P/E of 16.7.

What is the stock symbol of Modern Diagnostic & Research C?

Modern Diagnostic & Research C is listed on the BSE under the scrip code 544673.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.